
News|Articles|October 2, 2013
Cambridge Major Laboratories and AAIPharma To Merge
Author(s)Pharmaceutical Technology Editors
Cambridge Major Laboratories and AAIPharma Services plan to merge to form a global supplier of integrated CMC services.
Advertisement
, a CMO providing pharmaceutical API development and manufacturing, and AAIPharma Services, a provider of pharmaceutical analytical testing, product development, and manufacturing services, have announced their intent to merge to form a global supplier of integrated chemistry, manufacturing, and control (CMC) services. Financial terms of the merger were not disclosed. The merger is expected to close by the end of October 2013, subject to Hart-Scott-Rodino approval and other closing conditions.
Source:
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
European Biotechs Reshaping Respiratory Disease
2
GSK Cambridge Move Signals Shift in Drug Scale-Up Strategy
3
Midyear 2026 Industry Report: Taking Stock of Pharma Manufacturing, AI, and Regulatory Trends
4
Six Months In: A 2026 Progress Check on Pharma Manufacturing, AI, and Regulatory Shifts
5




